• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Metabolic conversion of indicine N-oxide to indicine in rabbits and humans.

作者信息

Powis G, Ames M M, Kovach J S

出版信息

Cancer Res. 1979 Sep;39(9):3564-70.

PMID:476682
Abstract

Indicine N-oxide, a pyrrolizidine alkaloid N-oxide that exhibits antitumor activity without some of the toxic effects associated with other pyrrolizidine alkaloids, is metabolized to indicine in rabbits and humans. Indicine can be detected in the plasma and is excreted in the urine in a dose-dependent manner following the i.v. administration of indicine N-oxide. The p.o. administration of indicine N-oxide leads to an increased plasma concentration and an increased urinary excretion of indicine. The hepatic microsomal fraction and the gut flora both catalyze the anaerobic reduction of indicine N-oxide to indicine in vitro. Whole-animal studies suggest that the gut flora play a major role in the metabolic reduction of indicine N-oxide by the rabbit. Indicine N-oxide is not actively excreted in the bile, and it is probable that indicine N-oxide finds its way into the gut by passive diffusion following i.v. administration. Neomycin and erythromycin, which reduce the number of anaerobic bacteria in the gut, lead to decreased plasma levels and a decreased urinary excretion of indicine.

摘要

相似文献

1
Metabolic conversion of indicine N-oxide to indicine in rabbits and humans.
Cancer Res. 1979 Sep;39(9):3564-70.
2
Relationship of the reductive metabolism of indicine N-oxide to its antitumor activity.印度牛N-氧化物的还原代谢与其抗肿瘤活性的关系。
Res Commun Chem Pathol Pharmacol. 1979 Jun;24(3):559-69.
3
N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions.血红蛋白、细胞色素C和亚铁离子对N-氧化物的还原作用。
Res Commun Chem Pathol Pharmacol. 1980 Oct;30(1):143-50.
4
Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.人肝微粒体将吡咯里西啶生物碱氮氧化物还原为相应的致癌母体生物碱。
Toxicol Lett. 2005 Mar 15;155(3):411-20. doi: 10.1016/j.toxlet.2004.11.010.
5
Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat.铁-乙二胺四乙酸刺激肝脏微粒体部分、分离的肝细胞及完整大鼠对印度獐牙菜碱N-氧化物的还原作用。
Biochem Pharmacol. 1982 Feb 1;31(3):293-9. doi: 10.1016/0006-2952(82)90173-3.
6
Determination of indicine N-oxide and indicine in plasma and urine by electron-capture gas-liquid chromatography.通过电子捕获气液色谱法测定血浆和尿液中的印度獐牙菜碱N-氧化物和印度獐牙菜碱。
J Chromatogr. 1978 Dec 11;166(2):519-26. doi: 10.1016/s0021-9673(00)95636-x.
7
Disposition of indicine N-oxide in mice and monkeys.印度獐牙菜N-氧化物在小鼠和猴子体内的处置情况。
Cancer Treat Rep. 1982 Jan;66(1):183-6.
8
The gas chromatographic mass spectrometric analysis of the new antitumor drug indicine-N-oxide utilizing a novel reaction accompanying trimethylsilylation.利用一种伴随三甲基硅烷化的新型反应对新型抗肿瘤药物印度獐牙菜素 - N - 氧化物进行气相色谱 - 质谱分析。
Biomed Mass Spectrom. 1979 Jan;6(1):38-43. doi: 10.1002/bms.1200060109.
9
Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450.肝脏微粒体细胞色素P-450还原印度牛N-氧化物对吡啶核苷酸辅因子的需求
Biochem Pharmacol. 1980 Feb;29(3):347-51. doi: 10.1016/0006-2952(80)90512-2.
10
Indicine-N-oxide: a new antitumor agent.印度豆碱 - N - 氧化物:一种新型抗肿瘤药物。
Cancer Treat Rep. 1981 Jan-Feb;65(1-2):53-6.

引用本文的文献

1
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.微生物代谢的奇迹:微生物药物转化能力的综合评述。
Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16.
2
Medicinal Chemistry of Drugs with -Oxide Functionalities.含 -氧化物官能团药物的药物化学
J Med Chem. 2024 Apr 11;67(7):5168-5184. doi: 10.1021/acs.jmedchem.4c00254. Epub 2024 Mar 29.
3
The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides.
吡咯里西啶生物碱及其 N-氧化物毒性的动力学作用作为关键决定因素。
Planta Med. 2022 Feb;88(2):130-143. doi: 10.1055/a-1582-9794. Epub 2021 Nov 5.
4
Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.基于生理学的动力学模型预测,与 riddelliine 相比, riddelliine N-氧化物在大鼠体内的相对效力与剂量有关。
Arch Toxicol. 2022 Jan;96(1):135-151. doi: 10.1007/s00204-021-03179-w. Epub 2021 Oct 20.
5
How to Determine the Role of the Microbiome in Drug Disposition.如何确定微生物组在药物处置中的作用。
Drug Metab Dispos. 2018 Nov;46(11):1588-1595. doi: 10.1124/dmd.118.083402. Epub 2018 Aug 15.
6
Dose-dependent exposure and metabolism of GNE-892, a β-secretase inhibitor, in monkeys: contributions by P450, AO, and P-gp.β-分泌酶抑制剂GNE-892在猴子体内的剂量依赖性暴露和代谢:细胞色素P450、醛氧化酶和P-糖蛋白的作用
Eur J Drug Metab Pharmacokinet. 2015 Jun;40(2):171-85. doi: 10.1007/s13318-014-0198-5. Epub 2014 Apr 3.
7
Pyrrolizidine alkaloids from Symphytum officinale L. and their percutaneous absorption in rats.
Experientia. 1982 Sep 15;38(9):1085-7. doi: 10.1007/BF01955382.